Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care

Mayo Clinic Proceedings

Volumn 92, Issue 7, 2017, Pages 1104-1112

  Mirza, Shireen ^a   Benzo, Roberto ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BRONCHODILATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; PHOSPHODIESTERASE IV INHIBITOR;

AIRFLOW; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL OUTCOME; COGNITIVE BEHAVIORAL THERAPY; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EMOTIONAL FRAILTY; EMPHYSEMA; FRAILTY; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HUMAN; LUNG FUNCTION; LUNG RESECTION; PHENOTYPE; PHYSICAL FRAILTY; PROGNOSIS; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; GENETIC PREDISPOSITION; GENETICS;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 85028517766     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2017.03.020     Document Type: Review

References (38)

1. American Thoracic Society. Standards for the Diagnosis and Care of Patients With Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 152:5 pt 2 (1995), S77–S121.
2. Han, M.K., Agusti, A., Calverley, P.M., et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:5 (2010), 598–604.
3. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2017 Report. http://goldcopd.org/. Accessed March 27, 2017.
4. Pinto, L.M., Alghamdi, M., Benedetti, A., Zaihra, T., Landry, T., Bourbeau, J., Derivation and validation of clinical phenotypes for COPD: a systematic review. Respir Res, 16, 2015, 50.
5. Postma, D.S., Rabe, K.F., The asthma-COPD overlap syndrome. N Engl J Med 373:13 (2015), 1241–1249.
6. Ding, B., Enstone, A., Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights. Expert Rev Respir Med 10:3 (2016), 363–371.
7. Cosentino, J., Zhao, H., Hardin, M., et al., COPDGene Investigators. Analysis of asthma-chronic obstructive pulmonary disease overlap syndrome defined on the basis of bronchodilator response and degree of emphysema. Ann Am Thorac Soc 13:9 (2016), 1483–1489.
8. Kumbhare, S., Pleasants, R., Ohar, J.A., Strange, C., Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States. Ann Am Thorac Soc 13:6 (2016), 803–810.
9. Lange, P., Çolak, Y., Ingebrigtsen, T.S., Vestbo, J., Marott, J.L., Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart Study: a prospective population-based analysis. Lancet Respir Med 4:6 (2016), 454–462.
10. Christenson, S.A., Steiling, K., van den Berge, M., et al. Asthma-COPD overlap: clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 191:7 (2015), 758–766.
11. Soler-Cataluña, J.J., Cosío, B., Izquierdo, J.L., et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 48:9 (2012), 331–337.
12. Global Initiative for Asthma, Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). http://ginasthma.org/asthma-copd-and-asthma-copd-overlap-syndrome-acos/. Published 2015. Accessed September 27, 2016.
13. Hurst, J.R., Vestbo, J., Anzueto, A., et al., Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363:12 (2010), 1128–1138.
14. Halpin, D.M., Decramer, M., Celli, B., Kesten, S., Liu, D., Tashkin, D.P., Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis 7 (2012), 653–661.
15. Yang, H., Xiang, P., Zhang, E., et al. Predictors of exacerbation frequency in chronic obstructive pulmonary disease. Eur J Med Res, 19, 2014, 18.
16. Laurin, C., Moullec, G., Bacon, S.L., Lavoie, K.L., Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med 185:9 (2012), 918–923.
17. Criner, G.J., Bourbeau, J., Diekemper, R.L., et al. Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 147:4 (2015), 894–942.
18. Tricco, A.C., Strifler, L., Veroniki, A.A., et al. Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis. BMJ Open, 5(10), 2015, e009183.
19. Zheng, J.P., Wen, F.Q., Bai, C.X., et al., PANTHEON study group. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. [published correction appears in Lancet Respir Med. 2014;2(4):e4] Lancet Respir Med 2:3 (2014), 187–194.
20. Albert, R.K., Connett, J., Bailey, W.C., et al., COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. [published correction appears in N Engl J Med. 2012;366(14):1356] N Engl J Med 365:8 (2011), 689–698.
21. Herath, S.C., Poole, P., Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev(11), 2013, CD009764.
22. Wedzicha, J.A., Calverley, P.M., Rabe, K.F., Roflumilast: a review of its use in the treatment of COPD. Int J Chron Obstruct Pulmon Dis 11 (2016), 81–90.
23. Fishman, A., Martinez, F., Naunheim, K., et al., National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 348:21 (2003), 2059–2073.
24. Koskela, J., Kilpeläinen, M., Kupiainen, H., et al. Co-morbidities are the key nominators of the health related quality of life in mild and moderate COPD. BMC Pulm Med, 14, 2014, 102.
25. Mittal, N., Raj, R., Islam, E.A., Nugent, K., The frequency of frailty in ambulatory patients with chronic lung diseases. J Prim Care Community Health 7:1 (2016), 10–15.
26. Park, S.K., Richardson, C.R., Holleman, R.G., Larson, J.L., Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003-2006). Heart Lung 42:3 (2013), 163–170.
27. Lahousse, L., Ziere, G., Verlinden, V.J., et al. Risk of frailty in elderly with COPD: a population-based study. J Gerontol A Biol Sci Med Sci 71:5 (2016), 689–695.
28. Maddocks, M., Kon, S.S., Canavan, J.L., et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax 71:11 (2016), 988–995.
29. Clegg, A., Rogers, L., Young, J., Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review. Age Ageing 44:1 (2015), 148–152.
30. Pooler, A., Beech, R., Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obstruct Pulmon Dis 9 (2014), 315–330.
31. Xu, W., Collet, J.P., Shapiro, S., et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 178:9 (2008), 913–920.
32. Benzo, R.P., Abascal-Bolado, B., Dulohery, M.M., Self-management and quality of life in chronic obstructive pulmonary disease (COPD): the mediating effects of positive affect. Patient Educ Couns 99:4 (2016), 617–623.
33. Papava, I., Oancea, C., Enatescu, V.R., et al. The impact of coping on the somatic and mental status of patients with COPD: a cross-sectional study. Int J Chron Obstruct Pulmon Dis 11 (2016), 1343–1351.
34. Abascal-Bolado, B., Novotny, P.J., Sloan, J.A., Karpman, C., Dulohery, M.M., Benzo, R.P., Forecasting COPD hospitalization in the clinic: optimizing the chronic respiratory questionnaire. Int J Chron Obstruct Pulmon Dis 10 (2015), 2295–2301.
35. Yohannes, A.M., Alexopoulos, G.S., Depression and anxiety in patients with COPD. Eur Respir Rev 23:133 (2014), 345–349.
36. Farver-Vestergaard, I., Jacobsen, D., Zachariae, R., Efficacy of psychosocial interventions on psychological and physical health outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Psychother Psychosom 84:1 (2015), 37–50.
37. Coventry, P.A., Bower, P., Keyworth, C., et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One, 8(4), 2013, e60532.
38. Wiles, L., Cafarella, P., Williams, M.T., Exercise training combined with psychological interventions for people with chronic obstructive pulmonary disease. Respirology 20:1 (2015), 46–55.